Accuracy analysis of a type of HBV DNA quantitative detection reagent

Kong Xiang-sha,Yang Rui-feng,Ji Ying,Zhu Ling,Zhang Hai-ying,Wang Zhen-yu,Wei Lai
DOI: https://doi.org/10.3969/j.issn.1005-8982.2018.10.009
2018-01-01
Abstract:Objective To evaluate and analyze the accuracy of a new type of HBV DNA quantitative detection reagent. Methods The 3rd generation HBV DNA WHO international standard was diluted into 6 samples of different concentrations, i.e. 8.5×105, 8.5×104, 8.5×103, 8.5×102, 85 and 42.5 IU/ml. The linear correlations between the theoretical values and the results detected by careHBV PCR Assay V3.0 were analyzed. With Cobas Taqman HBV V2.0 as the reference, HBV DNA content of the specimens from 93 patients infected by HBV and 30 healthy donors were detected by careHBV PCR Assay V3.0 and Cobas Taqman HBV V2.0 simultaneously. And the correlation and consistency of the loads of HBV DNA between the two kinds of results were analyzed. HBV S zone of the samples undetected by careHBV PCR Assay V3.0 was amplified using nested PCR, then the genotypes were determined by direct sequencing. Results The results of the WHO international standard detected by careHBV PCR Assay V3.0 were linearly associated with the theoretical values (R2= 0.993, P = 0.000). Among the 93 patients infected by HBV, 68 samples were positive by both kinds of quantitative reagents, and the two results were in linear association (R2= 0.947, P = 0.000); there was no statistical significance between them (t = 1.204, P = 0.231), but the loads of HBV DNA detected by careHBV PCR Assay V3.0 were relatively lower. There were 14 (15.05%) samples undetected by careHBV PCR Assay V3.0, including 13 (46.43%) samples with the results between 30 and 2 000 IU/ml detected by Cobas Taqman HBV V2.0, the genotype of 1 undetected sample was determined to be genotype C. Conclusions The loads of HBV DNA detected by careHBV PCR Assay V3.0 are correlated well with the results detected by Cobas Taqman V2.0. But there may be missed detection of genotype C samples by careHBV PCR Assay V3.0.
What problem does this paper attempt to address?